CG Oncology CGON Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by CG Oncology in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about CG Oncology's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CG Oncology's operating lease liabilities?
- CG Oncology (CGON) reported operating lease liabilities of $3.51M in Q1 2026.
- How has CG Oncology's operating lease liabilities changed year-over-year?
- CG Oncology's operating lease liabilities increased by 349.3% year-over-year, from $781K to $3.51M.
- What is the long-term trend for CG Oncology's operating lease liabilities?
- Over 2 years (2023 to 2025), CG Oncology's operating lease liabilities has grown at a 256.8% compound annual growth rate (CAGR), from $244K to $3.11M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.